v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flows from Operating Activities:    
Net income $ 161,059 $ 247,240
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 160,739 157,523
Unit-based compensation expense 4,820 0
Amortization of debt related items 5,762 6,693
Gain from sale or disposition of assets (14) (1,632)
Gain associated with the Linden Acquisition 0 (56,277)
Deferred income tax expense 2,989 626
Distributions of equity in earnings of joint venture 0 2,500
Changes in current assets and current liabilities (Note 12) (12,477) 19,803
Other, net (8,329) (352)
Net cash provided by operating activities 314,549 376,124
Cash Flows from Investing Activities:    
Capital expenditures (145,414) (240,671)
Change in accounts payable related to capital expenditures (15,504) (7,802)
Acquisitions 0 (142,500)
Investment in other long-term assets 0 (3,587)
Proceeds from sale or disposition of assets 0 17,125
Net cash used in investing activities (160,918) (377,435)
Cash Flows from Financing Activities:    
Proceeds from long-term debt borrowings 523,982 747,779
Proceeds from short-term debt borrowings 462,000 622,000
Long-term debt repayments (410,750) (365,410)
Short-term debt repayments (539,000) (657,000)
Proceeds from issuance of common units, net of issuance costs 27,710 0
Contributions from general partner 575 0
Distributions to unitholders and general partner (294,153) (294,153)
Decrease in cash book overdrafts (12,181) (12,281)
Other, net (1,418) (792)
Net cash (used in) provided by financing activities (243,235) 40,143
Effect of foreign exchange rate changes on cash 3,404 (10,319)
Net (decrease) increase in cash and cash equivalents (86,200) 28,513
Cash and cash equivalents as of the beginning of the period 118,862 87,912
Cash and cash equivalents as of the end of the period $ 32,662 $ 116,425